{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:20:13Z","timestamp":1782800413869,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jmgm.2021.108050","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T09:29:19Z","timestamp":1634030959000},"page":"108050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Small molecule interactions with the SARS-CoV-2 main protease: In silico all-atom microsecond MD simulations, PELE Monte Carlo simulations, and determination of in vitro activity inhibition"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3031-3169","authenticated-orcid":false,"given":"Julia","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Pitsillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1678-2767","authenticated-orcid":false,"given":"Katherine","family":"Ververis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Guallar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom C.","family":"Karagiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7798","key":"10.1016\/j.jmgm.2021.108050_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jmgm.2021.108050_bib2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Gorbalenya","year":"2020","journal-title":"Nature Microbiology"},{"key":"10.1016\/j.jmgm.2021.108050_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.jmgm.2021.108050_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.jmgm.2021.108050_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12967-020-02507-5","article-title":"Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1","volume":"18","author":"Benedetti","year":"2020","journal-title":"J. Transl. Med."},{"issue":"12","key":"10.1016\/j.jmgm.2021.108050_bib6","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-CoV-2 transmission and pathogenesis","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.jmgm.2021.108050_bib7","doi-asserted-by":"crossref","first-page":"e21573","DOI":"10.1096\/fj.202100280RR","article-title":"Potential 3-chymotrypsin-like cysteine protease cleavage sites in the coronavirus polyproteins pp1a and pp1ab and their possible relevance to COVID-19 vaccine and drug development","volume":"35","author":"Yan","year":"2021","journal-title":"Faseb. J."},{"issue":"21","key":"10.1016\/j.jmgm.2021.108050_bib8","doi-asserted-by":"crossref","first-page":"12544","DOI":"10.1021\/acscatal.0c03420","article-title":"Unraveling the SARS-CoV-2 main protease mechanism using multiscale methods","volume":"10","author":"Ramos-Guzm\u00e1n","year":"2020","journal-title":"ACS Catal."},{"issue":"7811","key":"10.1016\/j.jmgm.2021.108050_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"6489","key":"10.1016\/j.jmgm.2021.108050_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jmgm.2021.108050_bib11","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1038\/s41467-020-19662-4","article-title":"Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"issue":"50","key":"10.1016\/j.jmgm.2021.108050_bib12","first-page":"6","article-title":"Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L","author":"Sacco","year":"2020","journal-title":"Science Advances"},{"key":"10.1016\/j.jmgm.2021.108050_bib13","doi-asserted-by":"crossref","unstructured":"Mengist HM, Dilnessa T, Jin T. Structural basis of potential inhibitors targeting SARS-CoV-2 main protease. 2021;9(7).","DOI":"10.3389\/fchem.2021.622898"},{"issue":"6542","key":"10.1016\/j.jmgm.2021.108050_bib14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1126\/science.abf7945","article-title":"X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease","volume":"372","author":"G\u00fcnther","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2021.108050_bib15","doi-asserted-by":"crossref","first-page":"107372","DOI":"10.1016\/j.compbiolchem.2020.107372","article-title":"Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface","volume":"89","author":"Liang","year":"2020","journal-title":"Comput. Biol. Chem."},{"issue":"52","key":"10.1016\/j.jmgm.2021.108050_bib16","doi-asserted-by":"crossref","first-page":"23544","DOI":"10.1002\/anie.202010316","article-title":"Allosteric inhibition of the SARS-CoV-2 main protease: insights from mass spectrometry based assays**","volume":"59","author":"El-Baba","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jmgm.2021.108050_bib17","unstructured":"Jim\u00e9nez-Avalos G, Vargas-Ruiz AP, Delgado-Pease NE, Olivos-Ramirez GE, Sheen P, Fern\u00e1ndez-D\u00edaz M, et al. Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 MPRO. Sci. Rep.. 2021;11(1):15452."},{"key":"10.1016\/j.jmgm.2021.108050_bib18","doi-asserted-by":"crossref","unstructured":"Men\u00e9ndez Cintia A, Byl\u00e9hn F, Perez-Lemus Gustavo R, Alvarado W, de Pablo Juan J. Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease. Science Advances.6(37):eabd0345.","DOI":"10.1126\/sciadv.abd0345"},{"issue":"11","key":"10.1016\/j.jmgm.2021.108050_bib19","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/prot.26164","article-title":"Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease","volume":"89","author":"Yuce","year":"2021","journal-title":"Proteins: Structure, Function, and Bioinformatics"},{"key":"10.1016\/j.jmgm.2021.108050_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107408","article-title":"Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay","volume":"89","author":"Pitsillou","year":"2020","journal-title":"Comput. Biol. Chem."},{"issue":"9","key":"10.1016\/j.jmgm.2021.108050_bib21","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1021\/acs.jmedchem.9b01828","article-title":"\u03b1-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment","volume":"63","author":"Zhang","year":"2020","journal-title":"J. Med. Chem."},{"issue":"39","key":"10.1016\/j.jmgm.2021.108050_bib22","doi-asserted-by":"crossref","first-page":"10626","DOI":"10.1039\/D0SC02823A","article-title":"Revealing the molecular mechanisms of proteolysis of SARS-CoV-2 Mpro by QM\/MM computational methods","volume":"11","author":"\u015awiderek","year":"2020","journal-title":"Chem. Sci."},{"issue":"1","key":"10.1016\/j.jmgm.2021.108050_bib23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41467-021-20900-6","article-title":"A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication","volume":"12","author":"S-i","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jmgm.2021.108050_bib24","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1038\/s41467-020-18233-x","article-title":"Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease","volume":"11","author":"Fu","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jmgm.2021.108050_bib25","first-page":"15","article-title":"In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation","author":"Choudhary","year":"2020","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jmgm.2021.108050_bib26","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jiph.2020.06.016","article-title":"In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing","volume":"13","author":"Kumar","year":"2020","journal-title":"J Infect Public Health"},{"issue":"8","key":"10.1016\/j.jmgm.2021.108050_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202100028","article-title":"In silico studies on the interaction between Mpro and PLpro from SARS-CoV-2\u2009and ebselen, its metabolites and derivatives","volume":"40","author":"Nogara","year":"2021","journal-title":"Molecular Informatics"},{"key":"10.1016\/j.jmgm.2021.108050_bib28","doi-asserted-by":"crossref","unstructured":"Teli DM, Shah MB, Chhabria MT. In silico screening of natural compounds as potential inhibitors of SARS-CoV-2 main protease and spike RBD: targets for COVID-19. 2021;7(429).","DOI":"10.3389\/fmolb.2020.599079"},{"key":"10.1016\/j.jmgm.2021.108050_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107292","article-title":"Interaction of the prototypical \u03b1-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: molecular dynamic simulations highlight the stability of the ligand-protein complex","volume":"87","author":"Liang","year":"2020","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.jmgm.2021.108050_bib30","first-page":"1","article-title":"Natural-like products as potential SARS-CoV-2 Mpro inhibitors: in-silico drug discovery","author":"Ibrahim","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"5","key":"10.1016\/j.jmgm.2021.108050_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13659-020-00253-1","article-title":"Recognition of natural products as potential inhibitors of COVID-19 main protease (Mpro): in-silico evidences","volume":"10","author":"Narkhede","year":"2020","journal-title":"Natural Products and Bioprospecting"},{"key":"10.1016\/j.jmgm.2021.108050_bib32","first-page":"1","article-title":"Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease","author":"S","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2021.108050_bib33","first-page":"1","article-title":"Determination of potential drug candidate molecules of the Hypericum perforatum for COVID-19 treatment","author":"Yal\u00e7\u0131n","year":"2021","journal-title":"Curr Pharmacol Rep"},{"key":"10.1016\/j.jmgm.2021.108050_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198068","article-title":"Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors","volume":"286","author":"Romeo","year":"2020","journal-title":"Virus Res."},{"issue":"9","key":"10.1016\/j.jmgm.2021.108050_bib35","first-page":"3213","article-title":"A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2","volume":"39","author":"Islam","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2021.108050_bib36","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3389\/fphar.2019.01207","article-title":"The signaling pathways, and therapeutic targets of antiviral agents: focusing on the antiviral approaches and clinical perspectives of anthocyanins in the management of viral diseases","volume":"10","author":"Mohammadi Pour","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jmgm.2021.108050_bib37","doi-asserted-by":"crossref","unstructured":"Jend\u017eelovsk\u00e1 Z, Jend\u017eelovsk\u00fd R, Kuch\u00e1rov\u00e1 B, Fedoro\u010dko P. Hypericin in the light and in the dark: two sides of the same coin. 2016;7(560).","DOI":"10.3389\/fpls.2016.00560"},{"issue":"8","key":"10.1016\/j.jmgm.2021.108050_bib38","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1080\/13880200902988645","article-title":"Hypericum in infection: identification of anti-viral and anti-inflammatory constituents","volume":"47","author":"Birt","year":"2009","journal-title":"Pharm. Biol."},{"issue":"2","key":"10.1016\/j.jmgm.2021.108050_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/095632029400500204","article-title":"The antiviral agent hypericin has in vitro activity against HSV-1 through non-specific association with viral and cellular membranes","volume":"5","author":"Weber","year":"1994","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.jmgm.2021.108050_bib40","doi-asserted-by":"crossref","unstructured":"Chen H, Muhammad I, Zhang Y, Ren Y, Zhang R, Huang X, et al. Antiviral activity against infectious bronchitis virus and bioactive components of Hypericum perforatum L. 2019;10(1272).","DOI":"10.3389\/fphar.2019.01272"},{"issue":"2","key":"10.1016\/j.jmgm.2021.108050_bib41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bcp.2014.05.004","article-title":"Cyanidin-3-O-\u03b2-glucoside ameliorates lipopolysaccharide-induced acute lung injury by reducing TLR4 recruitment into lipid rafts","volume":"90","author":"Fu","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.jmgm.2021.108050_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/cancers9020019","article-title":"Oncologic photodynamic therapy: basic principles, current clinical status and future directions","volume":"9","author":"van Straten","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.jmgm.2021.108050_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.107851","article-title":"Interaction of small molecules with the SARS-CoV-2 papain-like protease: in silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay","volume":"104","author":"Pitsillou","year":"2021","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2021.108050_bib44","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Protein interfaces, surfaces and assemblies service PISA at European Bioinformatics Institute","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."},{"issue":"11","key":"10.1016\/j.jmgm.2021.108050_bib45","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: a fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.jmgm.2021.108050_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-E","article-title":"GROMACS: a message-passing parallel molecular dynamics implementation","volume":"91","author":"Berendsen","year":"1995","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.jmgm.2021.108050_bib47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"Software"},{"issue":"2","key":"10.1016\/j.jmgm.2021.108050_bib48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/ct900549r","article-title":"Implementation of the CHARMM force field in GROMACS: analysis of protein stability effects from correction maps, virtual interaction sites, and water models","volume":"6","author":"Bjelkmar","year":"2010","journal-title":"J. Chem. Theor. Comput."},{"issue":"4","key":"10.1016\/j.jmgm.2021.108050_bib49","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM General Force Field (CGenFF): a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.jmgm.2021.108050_bib50","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"issue":"8","key":"10.1016\/j.jmgm.2021.108050_bib51","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"issue":"14","key":"10.1016\/j.jmgm.2021.108050_bib52","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1103\/PhysRevLett.45.1196","article-title":"Crystal structure and pair potentials: a molecular-dynamics study","volume":"45","author":"Parrinello","year":"1980","journal-title":"Phys. Rev. Lett."},{"issue":"12","key":"10.1016\/j.jmgm.2021.108050_bib53","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"issue":"12","key":"10.1016\/j.jmgm.2021.108050_bib54","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"1","key":"10.1016\/j.jmgm.2021.108050_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"issue":"4","key":"10.1016\/j.jmgm.2021.108050_bib56","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/prot.340170408","article-title":"Essential dynamics of proteins","volume":"17","author":"Amadei","year":"1993","journal-title":"Proteins"},{"issue":"1","key":"10.1016\/j.jmgm.2021.108050_bib57","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1038\/s41598-017-08445-5","article-title":"Adaptive simulations, towards interactive protein-ligand modeling","volume":"7","author":"Lecina","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jmgm.2021.108050_bib58","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1742-4658.2006.05130.x","article-title":"The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain","volume":"273","author":"Shi","year":"2006","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.jmgm.2021.108050_bib59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jmb.2005.09.012","article-title":"pH-dependent conformational flexibility of the SARS-CoV main proteinase (Mpro) dimer: molecular dynamics simulations and multiple X-ray structure analyses","volume":"354","author":"Tan","year":"2005","journal-title":"J. Mol. Biol."},{"issue":"9","key":"10.1016\/j.jmgm.2021.108050_bib60","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1128\/JVI.02680-07","article-title":"Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease","volume":"82","author":"Shi","year":"2008","journal-title":"J. Virol."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326321002217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326321002217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:07:46Z","timestamp":1761080866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326321002217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":60,"alternative-id":["S1093326321002217"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2021.108050","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small molecule interactions with the SARS-CoV-2 main protease: In silico all-atom microsecond MD simulations, PELE Monte Carlo simulations, and determination of in vitro activity inhibition","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2021.108050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108050"}}